An in silico approach to design potential siRNA molecules for ICP22 (US1) gene silencing of different strains of human herpes simplex 1

Journal of Young Pharmacists

Volumn 5, Issue 2, 2013, Pages 46-49

  Nur, Suza Mohammad ^a   Al Amin, Mohammad ^a   Alam, Rashel ^a   Hasan, Md Anayet ^a   Hossain, Md Amzad ^a   Mannan, Adnan ^a,b  

^a UNIVERSITY OF CHITTAGONG   (Bangladesh)

^b CURTIN UNIVERSITY   (Australia)

Author keywords

Antiviral; HSV 1; ICP22 (US1) gene; RNAi; siRNA

Indexed keywords

SMALL INTERFERING RNA;

ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; DNA SEQUENCE; EXPERIMENTAL DESIGN; GENE IDENTIFICATION; GENE SILENCING; GENETIC VARIABILITY; GENOME ANALYSIS; HERPES SIMPLEX VIRUS 1; ICP22 GENE; IMMEDIATE EARLY GENE; MOLECULAR DYNAMICS; MOLECULAR PHYLOGENY; NONHUMAN; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; RNA INTERFERENCE; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; STRAIN DIFFERENCE; VIRUS GENOME; VIRUS ISOLATION; VIRUS REPLICATION; VIRUS STRAIN;

EID: 84883445125     PISSN: 09751483     EISSN: 09751505     Source Type: Journal    
DOI: 10.1016/j.jyp.2013.05.001     Document Type: Article

References (20)

1. J. Huff, and P. Barry B-virus (Cercopithecine herpesvirus 1) infection in humans and macaques: potential for zoonotic disease Emerg Infect Dis 9 2003 246 250
2. D.J. McGeoch, F.J. Rixon, and A.J. Davison Topics in herpesvirus genomics and evolution Virus Res 117 2006 90 104
3. D.M. Koelle, and L. Corey Herpes simplex: insights on pathogenesis and possible vaccines Annu Rev Med 59 2008 381 395
4. R.P. Subramanian, and R.J. Geraghty Herpes simplex virus type 1 mediates fusion through a hemifusion intermediate by sequential activity of glycoproteins D, H, L, and B Proc Natl Acad Sci USA 104 2007 2903 2908
5. J. Matis, and M. Kúdelová Early shutoff of host protein synthesis in cells infected with herpes simplex viruses Acta Virol 45 2001 269 277
6. J. Rajcáni, V. Andrea, and R. Ingeborg Peculiarities of herpes simplex virus (HSV) transcription: an overview Virus Genes 28 2004 293 310
7. K.M. Hoque, M.F. Azim, and M.R. Mia Design of potential siRNA molecules for T antigen gene silencing of Merkel Cell Polyomavirus Bioinformation 8 2012 924 930
8. N. Saengkrit, P. Sanitrum, and N. Woramongkolchai The PEI-introduced CS shell/PMMA core nanoparticle for silencing the expression of E6/E7 oncogenes in human cervical cells Carbohydr Polym 90 2012 1323 1329
9. A.J. Geall, A. Verma, and G.R. Otten Nonviral delivery of self-amplifying RNA vaccines Proc Natl Acad Sci USA 109 Sep 4, 2012 14604 14609
10. D.J. Taxman, L.R. Livingstone, and J. Zhang Criteria for effective design, construction, and gene knockdown by shRNA vectors BMC Biotechnol 6 2006 7
11. K. Ui-Tei, Y. Naito, K. Nishi, A. Juni, and K. Saigo Thermodynamic stability and Watson-Crick base pairing in the seed duplex are major determinants of the efficiency of the siRNA-based off-target effect Nucleic Acids Res 36 2008 7100 7109
12. A.L. Jackson, and P.S. Linsley Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application Nat Rev Drug Discov 9 2010 57 67
13. C.Y. Chan, C.S. Carmack, and D.D. Long A structural interpretation of the effect of GC-content on efficiency of RNA interference BMC Bioinform 10 2009 S33
14. S. Singh, S.K. Gupta, and A. Nischal Design of potential siRNA molecules for hepatitis delta virus gene silencing Bioinformation 8 2012 749 757
15. S.H. Bernhart, H. Tafer, U. Mückstein, C. Flamm, P.F. Stadler, and I.L. Hofacker Partition function and base pairing probabilities of RNA heterodimers Algorithms Mol Biol 1 2006 3
16. M. Motavaf, S. Safari, and S.M. Alavian Therapeutic potential of RNA interference: a new molecular approach to antiviral treatment for hepatitis C J Viral Hepat 19 2012 757 765
17. R.L. Boudreau, and B.L. Davidson RNAi therapeutics for CNS disorders Brain Res 1338 2010 112 121
18. M.P. Czech, M. Aouadi, and G.J. Tesz RNAi-based therapeutic strategies for metabolic disease Nat Rev Endocrinol 7 2011 473 484
19. W.S. Park, N. Miyano-Kurosaki, and M. Hayafune Prevention of HIV-1 infection in human peripheral blood mononuclear cells by specific RNA interference Nucleic Acids Res 30 2002 4830 4835
20. Z.X. Zhang, W.P. Min, and A.M. Jevnikar Use of RNA interference to minimize ischemia reperfusion injury Transplant Rev (Orlando) 26 2012 140 155